Nano-medicinal carrier with magnetocaloric effect as well as preparation method and application thereof
A nano drug carrier and magnetocaloric effect technology, applied in the field of medicine, can solve the problems of reducing drug efficacy, poor selectivity of chemotherapy drugs, killing normal cells, etc., achieve good delivery efficiency, increase storage capacity, and reduce complications
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0034]
[0035] The nano-medicine carrier provided in this embodiment includes mesoporous silica particles and Fe embedded in the mesoporous silica particles. 3 O 4 Nano particles. The preparation method of the nano medicine carrier includes the following steps:
[0036] Step 1: Take FeCl 3 ·6H 2 O and FeCl 2 ·4H 2 Each 19.2 mmol of O was dissolved in 25 ml of deionized water and then 0.85 ml of concentrated hydrochloric acid (36-38%) was added; then 250 ml of 1.5 mol / L sodium hydroxide solution was added dropwise to the above solution, and Stir at 700 rpm for 1 hour at room temperature, resulting in a black precipitate.
[0037] Step 2: Collect the black precipitate with a magnet block, wash the black precipitate with deionized water three times, and then wash three times with ethanol, and finally vacuum dry at 60°C for 24 hours to obtain Fe 3 O 4 Nano particles.
[0038] Step 3: Take 0.4g Fe 3 O 4 Nanoparticles were dispersed in 36 ml of ultrapure water by ultrasound, 0.6836 g of ...
Example Embodiment
[0044]
[0045] The nano drug carrier provided in this embodiment is an amino-modified nano drug carrier, the silane coupling agent used is γ-aminopropyltriethoxysilane, and the preparation method is:
[0046] Take 1 gram of the nano drug carrier prepared in Example 1, ultrasonically disperse it in absolute ethanol to obtain a suspension, then quickly add 3 ml of γ-aminopropyltriethoxysilane to the above suspension, seal the container and stir at room temperature for 24 hours After hours, the unreacted γ-aminopropyltriethoxysilane was washed away with absolute ethanol and dried in vacuum to obtain the amino-modified nano-medicine carrier.
[0047] The particle diameter of the amino-modified nano-medicine carrier is about 150 nanometers, and the average mesoporous pore diameter of the mesoporous silica particles is 3.2 nanometers.
[0048] In addition, the silane coupling agent used in this embodiment is γ-aminopropyltrimethoxysilane. The outer surface of the mesoporous silica particl...
Example Embodiment
[0049]
[0050] The nano-medicine carrier provided in this embodiment is an RBITC-modified nano-medicine carrier, which is used to observe the uptake of the nano-medicine carrier by a cell under a fluorescence microscope. The silane coupling agent used is RBITC-APTES silane coupling agent, and its preparation method is:
[0051] Take 15 mg of Rhodamine B isothiocyanate (RBITC) and 100 μl of γ-aminopropyltriethoxysilane, add 5 ml of absolute ethanol, and stir in a sealed container under dark room conditions for 24 After hours, a rhodamine B modified silane coupling agent (RBITC-APTES) was obtained.
[0052] Then, take 20 mg of the nano-medicine carrier prepared in Example 1, and disperse it in 6 ml of absolute ethanol, add 1 ml of RBITC-APTES silane coupling agent, and stir for 24 hours in a sealed container under dark room conditions. Finally, the above-mentioned particle solution is centrifuged, and washed with anhydrous ethanol several times to remove the unreacted RBITC-APTES s...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
Mesopore diameter | aaaaa | aaaaa |
Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap